Comparing stimulant effects in youth with ADHD symptoms and epilepsy

被引:19
作者
Gonzalez-Heydrich, Joseph [1 ]
Hsin, Olivia [1 ]
Gumlak, Sarah [1 ]
Kimball, Kara [1 ]
Rober, Ashley [1 ]
Azeem, Muhammad W. [2 ]
Hickory, Meredith [3 ]
Mrakotsky, Christine [1 ]
Torres, Alcy [4 ]
Mezzacappa, Enrico [1 ]
Bourgeois, Blaise [5 ]
Biederman, Joseph [6 ]
机构
[1] Harvard Univ, Sch Med, Dept Psychiat, Boston Childrens Hosp, Boston, MA 02115 USA
[2] Albert J Solnit Childrens Ctr, Middletown, CT USA
[3] Peak Dev Associates, Apex, NC USA
[4] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Epilepsy & Clin Neurophysiol, Boston, MA USA
[6] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA USA
关键词
Epilepsy; Seizures; ADHD; Stimulant; Methylphenidate; Amphetamine; Pharmacotherapy; Comorbidity; DEFICIT HYPERACTIVITY DISORDER; QUALITY-OF-LIFE; MENTAL-RETARDATION; BEHAVIOR PROBLEMS; CHILDREN; METHYLPHENIDATE; FREQUENCY; DIAGNOSIS; SEVERITY; RELEASE;
D O I
10.1016/j.yebeh.2014.04.026
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
To retrospectively examine response to stimulant treatment in patients with epilepsy and ADHD symptoms as predicted by seizure freedom for six months, use of methylphenidate (MPH) versus amphetamine (AMP) preparations, cognitive level, and medical records were searched for patients under the age of 18 with epilepsy and ADHD symptoms treated with MPH or AMP (n = 36, age = 10.4 +/- 3.5; male = 67%). "Responders" had a CGI-improvement score of <= 2 and did not stop medication because of adverse effects. "Worsened" patients discontinued medication because of agitation/emotional lability. Seizure freedom did not predict treatment response. Lower cognitive level was associated with increased rate of worsening (p = 0.048). No patients who were seizure-free at the start of the medication trial experienced an increase in seizures. Of the patients having seizures at the start of trial, one patient on MPH and two patients on AMP had increased seizures during the trial. Seizures returned to baseline frequency or less after stimulant discontinuation or anticonvulsant adjustment. Methylphenidate was associated with a higher response rate, with 12 of 19 given MPH (0.62 +/- 0.28 mg/kg/day) compared with 4 of 17 given AMP (0.37 +/- 0.26 mg/kg/day) responding (p = 0.03). Methylphenidate treatment and higher cognitive level were associated with improved treatment outcome, while seizure freedom had no clear effect. Confidence in these findings is limited by the study's small, open-label, and uncontrolled design. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 50 条
  • [31] ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate
    Rheims, Sylvain
    Herbillon, Vania
    Villeneuve, Nathalie
    Auvin, Stephane
    Napuri, Silvia
    Cances, Claude
    Berquin, Patrick
    Castelneau, Pierre
    Sylvie Nguyen The Tich
    Villega, Frederic
    Isnard, Herve
    Nabbout, Rima
    Gaillard, Segolene
    Mercier, Catherine
    Kassai, Behrouz
    Arzimanoglou, Alexis
    EPILEPSIA, 2016, 57 (07) : 1069 - 1077
  • [32] The Effects of Stimulant Medication on Free Recall of Story Events among Children with ADHD
    Bailey, Ursula L.
    Derefinko, Karen J.
    Milich, Richard
    Lorch, Elizabeth P.
    Metze, Amanda
    JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT, 2011, 33 (04) : 409 - 419
  • [33] Attention-Deficit Hyperactivity Disorder (ADHD) in Epilepsy and Primary ADHD: Differences in Symptom Dimensions and Quality of Life
    Ekinci, Ozalp
    Okuyaz, Cetin
    Erdogan, Semra
    Gunes, Serkan
    Ekinci, Nuran
    Kalinli, Merve
    Teke, Halenur
    Direk, Meltem Cobanogullari
    JOURNAL OF CHILD NEUROLOGY, 2017, 32 (14) : 1083 - 1091
  • [34] Stimulant use for ADHD and relative age in class among children in Israel
    Hoshen, Moshe B.
    Benis, Arriel
    Keyes, Katherine M.
    Zoega, Helga
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (06) : 652 - 660
  • [35] Dyskinesia in Treatment-Naive and Stimulant-Treated Children With ADHD
    Kereszteny, Agnes
    Ferenczi-Dallos, Gyongyver
    Velo, Szabina
    Gadoros, Julia
    Balazs, Judit
    JOURNAL OF ATTENTION DISORDERS, 2020, 24 (07) : 981 - 989
  • [36] CE Incremental Validity of Neuropsychological Assessment in the Identification and Treatment of Youth with ADHD
    Pritchard, Alison E.
    Koriakin, Taylor
    Jacobson, Lisa A.
    Mahone, E. Mark
    CLINICAL NEUROPSYCHOLOGIST, 2014, 28 (01) : 26 - 48
  • [37] Parent-reported symptoms of ADHD in young people with epilepsy before and two years after epilepsy surgery
    Reilly, Colin
    Hallbook, Tove
    Viggedal, Gerd
    Rydenhag, Bertil
    Uvebrant, Paul
    Olsson, Ingrid
    EPILEPSY & BEHAVIOR, 2019, 94 : 29 - 34
  • [38] Stimulant Medication for ADHD in Opioid Maintenance Treatment
    Abel, Kristine Fiksdal
    Bramness, Jorgen G.
    Martinsen, Egil W.
    JOURNAL OF DUAL DIAGNOSIS, 2014, 10 (01) : 32 - 38
  • [39] The effects of chronic administration of stimulant and non-stimulant medications on executive functions in ADHD: A systematic review and meta-analysis
    Isfandnia, Ferdous
    El Masri, Sahid
    Radua, Joaquim
    Rubia, Katya
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2024, 162
  • [40] Time Trends in the Frequencies of ADHD and Stimulant Medication
    Steinhausen, Hans-Christoph
    Doepfner, Manfred
    Schubert, Ingrid
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2016, 44 (04): : 275 - 284